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Abstract
Background: Type 2 diabetes mellitus is a complex, progressive disease which requires a variety of quality improvement
strategies. Limited information is available on the feasibility and effectiveness of interdisciplinary diabetes care teams (IDCT)
operating on the interface between primary and specialty care. A first study hypothesis was that the implementation of an IDCT
is feasible in a health care setting with limited tradition in shared care. A second hypothesis was that patients who make use of
an IDCT would have significantly better outcomes compared to non-users of the IDCT after an 18-month intervention period.
A third hypothesis was that patients who used the IDCT in an Advanced quality Improvement Program (AQIP) would have
significantly better outcomes compared to users of a Usual Quality Improvement Program (UQIP).
Methods: This investigation comprised a two-arm cluster randomized trial conducted in a primary care setting in Belgium.
Primary care physicians (PCPs, n = 120) and their patients with type 2 diabetes mellitus (n = 2495) were included and subjects
were randomly assigned to the intervention arms. The IDCT acted as a cornerstone to both the intervention arms, but the
number, type and intensity of IDCT related interventions varied depending upon the intervention arm.
Results: Final registration included 67 PCPs and 1577 patients in the AQIP and 53 PCPs and 918 patients in the UQIP. 84% of
the PCPs made use of the IDCT. The expected participation rate in patients (30%) was not attained, with 12,5% of the patients
using the IDCT. When comparing users and non-users of the IDCT (irrespective of the intervention arm) and after 18 months
of intervention the use of the IDCT was significantly associated with improvements in HbA1c, LDL-cholesterol, an increase in
statins and anti-platelet therapy as well as the number of targets that were reached. When comparing users of the IDCT in the
two intervention arms no significant differences were noted, except for anti-platelet therapy.
Conclusion: IDCT's operating on the interface between primary and specialty care are associated with improved outcomes of
care. More research is required on what team and program characteristics contribute to improvements in diabetes care.
Trial registration: NTR 1369.
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Background
Despite its multi-system effects, diabetes is a controllable
disease, and there is unequivocal evidence that early and
proactive, continuous monitoring and treatment can sig-
nificantly reduce its human and economic toll [1-3].
Many guidelines provide targets that are desirable for
most patients with diabetes[4]. Literature demonstrates
however that many patients with type 2 diabetes mellitus
(DM) still don't receive the care they need[5], as physi-
cians overrate the quality of the care they already deliver
and substantially underestimate the number of patients in
need of intensified pharmacotherapy and lifestyle inter-
ventions[6]. We therefore need quality improvement pro-
grams that promote comprehensive and proactive
diabetes care at different levels of the health care system.
Components of such care that many physicians find diffi-
cult to provide include risk factor reduction, periodic
examination for early signs of complications, ongoing
education and behavioral interventions and health pro-
motion[7]. The failure to initiate or to intensify therapy in
a patient not at evidence-based treatment targets is
defined as 'clinical inertia'[8]. Besides physician factors
the principal sources for clinical inertia include patient
factors (e.g. resistance to adopting lifestyles that support
optimal disease care) and organizational factors (e.g. a
lack of a team approach to care)[9,10]. These three sources
interact in complex ways and quality improvement inter-
ventions to reduce clinical inertia therefore need to be
multifactorial in nature[11]. A multifactorial approach to
chronic care delivery is advocated by multiple authors that
have developed conceptual models for this purpose [12-
14]. A widely used conceptual model for improving
chronic illness care is the Chronic Care Model
(CCM)[15]. Despite a diabetes prevalence rate of 7.9% in
Europe[16], very few countries in Europe have national or
even local programs that target this chronic condition
building on multiple dimensions of the CCM. Previous
studies have shown that it is not the intensity of the pro-
gram, i.e. the number dimensions of the CCM that are
applied which determines outcomes of care[17]. Impor-
tant predictors of success are the type of interventions and
the implementation strategies applied[18]. One such
important component of quality improvement programs
in diabetes care are considered interdisciplinary diabetes
care teams[19]. These teams often focus on clinical guid-
ance to primary care physicians and the provision of a
broad range of educational services to patients[20]. There
is a particular paucity of evidence with regard to the effec-
tiveness of interdisciplinary diabetes care teams operating
on the interface between primary and specialty care[21].
This interface refers to collaborative relationships between
primary and specialty care aimed at improvements in effi-
ciency and effectiveness of care. This study reports on the
effectiveness of primary care-based interdisciplinary dia-
betes care teams that are actively guided and supported by
a specialist team from secondary care. The teams are
embedded in a two-arm multifaceted quality improve-
ment program targeting adherence to guidelines and clin-
ical inertia in primary care physicians.
A first study hypothesis was that the implementation of an
interdisciplinary diabetes care team (IDCT) in support of
primary care physicians is feasible in a health care setting
with limited tradition in shared care. A second hypothesis
was that patients who make use of an IDCT would have
significantly better outcomes compared to non-users of
the IDCT (irrespective of the intervention arm) and after
an 18-month intervention period. A third hypothesis is
that patients who used the IDCT in an advanced quality
improvement program (AQIP) would have better out-
comes compared to users in a usual quality improvement
program (UQIP).
This study (The Leuven Diabetes Project) is intended to
create the basis for the development of a national diabetes
care program that set out national standards for the care
of people with diabetes with the aim to raise the quality of
services and to promote interdisciplinary shared care.
Methods
The study protocol of our trial has been peer-reviewed and
published previously[22]. We summarize information on
the study design, participants and key interventions of the
IDCT. For detailed information on the sample size, rand-
omization, allocation concealment, method for data col-
lection and detailed descriptions on the interventions
provided we refer to our study protocol and the CON-
SORT Checklist of items of cluster randomized trials[23],
as presented in Table 1.
Study design
The study was a cluster-randomized trial with before/after
measurements and two intervention arms. A cluster
design was necessary since randomization was performed
on a practice level, the intervention happened on the phy-
sician level, but a large part of the data were analyzed at
the patient level. The implementation period of the trial
was 18 months.
Participants
All 336 active primary care physicians (PCPs) in the
project region were invited to participate in the project.
These PCPs work in a semi-rural setting with 357.000
inhabitants and serve predominantly Caucasian patients
with type 2 diabetes mellitus. Primary care physicians pro-
vide care for approximately 80% of patients with type 2
diabetes, and are often the sole providers of care who have
no or limited experience with interdisciplinary shared
care. A fixed fee of 60 Euro was issued per registered
patient. The only inclusion criterion for the PCPs wasBMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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agreeing to recruit all patients with type 2 diabetes melli-
tus to prevent selection bias. Patients with diabetes were
identified using electronic searching in computerized
records and laboratory lists of patients with increased gly-
caemia or registered HbA1c. Diabetes was defined in
accordance with the 2003 ADA criteria[24] with PCPs
making the final diagnosis. Patients with type 1 DM and
those patients who could not provide informed consent
were excluded from the study. All patients were blinded to
the study design, but PCPs were not, as they were involved
in the execution of the programs. As a general referral
indication, PCPs were recommended to refer to the IDCT
in case treatment targets were not met, despite own
efforts. Patients only had access to the IDCT after referral
of their PCP. The interventions of the IDCT were free of
charge for all included patients.
Table 1: CONSORT Checklist of items of cluster randomized trials.
Paper section and topic Item Descriptor
Title and abstract
Design
1 → Interdisciplinary Diabetes Care Teams operating on the interface between primary and specialty care are 
associated with improved outcomes of care: Findings from the Leuven Diabetes Project.
Introduction
Background
2 → Scientific background and explanation of rationale: see Background section
→ Clustering: randomization at GP-level, primary/secondary outcomes at patient level.
→ Randomized per practice; stratified
Methods
Participants
3 → All 379 primary care physicians (PCP's) that actively execute their profession in the project region were 
invited to participate.
→ The only inclusion criterion for the PCP's is the agreement to bring in all their known patients with type 2 
diabetes mellitus. In this way selection bias is prevented. Patients had to provide informed consent before 
their data could be transmitted for collection and analysis. Only patients with type 2 diabetes mellitus were be 
included in the study, regardless of their age. Patients who were not capable to provide informed consent 
were excluded from the study.
→ Data were collected on paper files and from medical records
Interventions 4 → See methods section
Objectives 5 → See methods section
Outcomes 6 → The primary endpoints of the study were the proportion of patients reaching three clinical ADA-targets: 
(1) HbA1c < 7%; (2) SBD ≤ 130 mm Hg; (3) LDL-C < 100 mg/dl. Secondary endpoints were the mean 
improvements in individual parameters of 12 validated parameters, i.e. HbA1c, LDL-C, HDL-C, Total 
Cholesterol, SBP, Diastolic Blood Pressure (DBP), weight, physical exercise, healthy diet, smoking status, 
statin and anti-platelet therapy.
Sample size 7 → The financer to the project imposes a sample size of minimal one third of the potential PCP's. Using the 
calculator of the university of Aberdeen, sample size for cluster trials was computed. With a significance level 
of 0.05 and assumed Intra Cluster Coefficient of 0.1, we calculated that 114 clusters with a cluster size of 20 
gave 80% power to detect between AQIP and UQIP a 10% in the absolute difference in the proportion of 
patients achieving a 10% improvement in the primary biochemical endpoints. Based on the fitted mixed 
models the observed ICC values are: HBA1C: 0.0445, SBD: 0.0466, LDL Cholesterol: 0.0399.
Randomization
Sequence generation
8 → After the recruitment period, using computer-generated numbers, a researcher not involved the study and 
blind to the identity of the practices will perform a randomization stratified by practice size (solo/duo/group 
practice) and the presence/absence of an electronic medical recording system.
Allocation concealment 9 → Program Manager - invitation, stratified.
→ To minimize the possibility of selection bias all patients within a cluster were included
Implementation 10 → Allocation: Van Den Broeke Carine, researcher to the scientific team,
→ Enrollment: Borgermans Liesbeth, researcher to the scientific team,
→ Assignment: program manager
Blinding (masking) 11 → No blinding was possible at physician level, (both groups presented as 'intervention'), but patients didn't 
know to which intervention arm their physician belonged.
Statistical methods 12 → See methods section, sub-heading statistical analysis.BMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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Intervention
The UK Medical Research Council (MRC) Framework[25]
for the development and evaluation of complex interven-
tions for randomized control trials (RCT) was used as a
theoretical guide to designing the intervention. Two sepa-
rate groups were defined: the first group received a Usual
Quality Improvement Program (UQIP-program) and a
second group received an Advanced Quality Improvement
Program (AQIP-program). A summary of the differences
in interventions between the AQIP and the UQIP is pre-
sented in Table 2, 3 and 4. Briefly summarized, the UQIP
arm aimed to improve adherence to evidence-based
guidelines and to reduce the rate of clinical inertia in pri-
mary care physicians (PCPs). The term 'usual' was applied
since these interventions represent standard requirements
for improving the quality of diabetes care in most health
care systems[26]. The AQIP arm received identical inter-
ventions, but also included supplementary interventions
that extensively focused on behavior changes in patients
and providers.
The IDCT acted as a cornerstone to both the intervention
arms, but the number, type and intensity of IDCT related
interventions varied depending upon the intervention
arm. The IDCT was installed at two locations in a physi-
cian-led primary care center that was well known and
approachable to both PCPs and patients. A primary goal
of the IDCT was to support the physicians in the co-man-
agement of diabetes. The IDCT included a nurse educator,
an internist, a dietician and an ophthalmologist. The team
provided individual patient counseling, didactic goal set-
ting and situational problem solving as key educational
methods to both the intervention arms. A health psychol-
ogist was only available to physicians of the AQIP, as well
as a traveling educator providing education in the physi-
cian's practice or at the patient's home. Other interven-
tions that were only provided to the AQIP were group
educational sessions and the provision of structured edu-
cational materials for patients.
The IDCT was actively supervised by a diabetologist and
bi-weekly interdisciplinary meetings were organized
between the members of the team. Only physicians of the
AQIP were invited to the latter meetings to discuss com-
plex patient conditions. The IDCT met their colleagues
from the university hospital-based diabetes team on a
three-monthly basis to exchange experiences and to dis-
cuss complex patient cases. In addition, the internists of
the IDCT met the supervising diabetologist on a two-
monthly basis to discuss individual patient cases. Physi-
cians of the AQIP were actively encouraged on a three-
monthly basis to make use of the IDCT. All patient related
interventions of the IDCT were registered. Interventions
included consultations, telephone calls between a mem-
ber of the team and the GP, email and written reports.
Table 2: Interventions for UQIP versus AQIP (patient).
PATIENT
USUAL QUALITY IMPROVEMENT 
PROGRAM (UQIP)
ADVANCED QUALITY IMPROVEMENT 
PROGRAM (AQIP)
Patient education Medical assessments and education upon referral of 
the PCPs by diabetologist or Diabetes Care Team
= internist, nurse educator, dietician and 
ophthalmologist
Medical assessments and education upon referral of 
the PCPs by diabetologist or Diabetes Care Team
= internist, nurse educator, flying educator, dietician, 
ophthalmologist and health psychologist
Promotion of self-management ---- Education of patients in practice (by flying educator)
---- Education at patient's home (by flying educator)
---- Counseling by health psychologist
---- Structured educational materials from IDCT
---- Structured educational materials from community 
organizations
---- Group educational sessions for patients and family 
members
---- Free access to blood monitoring tools for self-
managementBMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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Variables
Dependent variables related to the first study hypothesis
on the feasibility of the IDCT were the use of the IDCT in
both physicians and patients for all caregivers of the IDCT.
The independent variable was the type of intervention
arm. The expected participation rate in physicians was set
at 80% whilst that in patients was set at 30%. Interna-
tional studies have shown that 30-70% of the patients
with type 2 DM in primary care settings are not at target
[27-29] of which some patients might benefit from serv-
ices provided by an interdisciplinary team. Since PCPs
currently provide 80% to 95% of diabetes care in Belgium,
which includes a broad range of medical, educational,
and psycho-social interventions in the management of
diabetes, we estimated that 30% of the patient population
in our project would benefit from co-management with a
diabetes team.
For the second study hypothesis on the effectiveness of the
IDCT, when comparing users and non-users, the depend-
ent variables were the proportion of patients reaching
three clinical ADA targets: (1) glycated hemoglobin
(HbA1c) < 7%; (2) systolic blood pressure (SBD) ≤ 130
mmHg; and (3) low density lipid cholesterol (LDL-C) <
100 mg/dl. Other dependent variables were the mean
improvements in individual values of 12 validated param-
eters: HbA1c, LDL-C, SBP, diastolic blood pressure (DBP),
high density lipid cholesterol (HDL-C), total cholesterol
(Tot. chol), weight, physical exercise, healthy diet, smok-
ing status, statin and anti-platelet therapy and the propor-
tion of patients reaching ADA targets. Independent
variables were the use or either non-use of the IDCT in all
patients. For the third hypothesis on the effectiveness of
the IDCT when comparing users of the IDCT in both the
intervention arms (AQIP and UQIP) the dependent varia-
bles were the same as for the second research hypothesis.
The independent variable was the type of intervention
arm.
Use of the IDCT was defined as having at least one consul-
tation with a member of the IDCT.
Statistical analysis
Baseline patient characteristics of IDCT users and non-
users were compared with t-tests for continuous and χ2-
tests for dichotomous outcomes, respectively. Endpoints
were analyzed according to the intent-to-treat approach.
Means and standard deviations were reported for contin-
Table 3: Interventions for UQIP versus AQIP (professional).
PROFESSIONAL
USUAL QUALITY IMPROVEMENT PROGRAM 
(UQIP)
ADVANCED QUALITY IMPROVEMENT PROGRAM 
(AQIP)
Clinician education Distribution of treatment protocol Distribution of treatment protocol
Two post-graduate educational sessions Four post-graduate educational sessions provided by 
diabetologist (opinion leader):
- Evidence based guidelines Evidence-based guidelines and principles of shared care
- The use of insulin The use of insulin
Patient-centered counseling
Peer review
Standard educational materials Extended educational materials
---- Inviting PCPs during IDCT meetings to discuss patient cases
---- Providing structured communication forms to PCPs by IDCT
---- Distribution of shared care protocol + referral indication
Feed-back At start and end of project: summary of clinical 
performance
Every 3 months: summaries of clinical performance
---- Every three months: benchmarking feed-back
Reminders Clinical reminders at start and end of project Every three months: Clinical reminders
---- Every three months: Shared care remindersBMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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uous outcomes, and proportions for dichotomous varia-
bles. In order to study the evolution of the various
outcomes over time, and to study how those evolutions
depend on patient and/or PCPs characteristics, including
use of IDCT, mixed models with random patient effects
were used, which correctly accounted for the clustered
nature of the repeated measurements within subjects.
Continuous outcomes were analyzed with linear mixed
models. Dichotomous outcomes were analyzed using
logistic mixed models. In the latter case, model fitting was
based on Gaussian quadrature with 200 quadrature
points. In order to test for differences between both inter-
vention arms, in the effects of IDCT use on patient out-
comes, multiple linear and logistic regression models
were used, whenever appropriate. Covariates included the
use of IDCT, intervention and their interaction. Note that
mixed models implicitly correct for baseline differences
between patients when comparing the intervention arms.
Alternatively, models could have been used which include
the baseline outcome values as covariates. A comparison
of several methods for correction for baseline differences
has been described by Verbeke and colleagues [30].
Recent research has shown that mixed models, as applied
in our analyses, have important advantages over other
models that include baseline values as covariates [31].
As this paper is exploratory in nature, where many poten-
tial effects were tested, no correction for multiple testing
has been performed. Effects that were found to be prom-
ising can be investigated in future studies. All analyses
were performed using SAS, version 9.
Results
Participant flow
Enrollment of physicians and patients in the study is pre-
sented in figure 1.
120 primary care physicians registered baseline data from
2495 patients (AQIP: 67 physicians, 1577 patients; UQIP
53 physicians, 918 patients). During the 18-month inter-
vention period 2 physicians and 239 patients dropped
out. Final results refer to 67 physicians, 42 practices and
1449 patients from the AQIP and 51 physicians, 32 prac-
tices and 807 patients from the UQIP.
Overall results
After 18 months of intervention a significant improve-
ment in all variables was noted (p < 0.0001), irrespective
of the intervention arm. When comparing the two inter-
vention arms (AQIP and UQIP) no significant differences
in outcomes were noted after 18 months of intervention.
A detailed analysis on the evolution of primary and sec-
ondary outcomes in all patients and for both the interven-
tion arms will be provided in a separate article.
Baseline characteristics of patients
Baseline information in users and non-users of the IDCT
and for AQIP and UQIP is presented in table 5 and 6
Table 4: Interventions for UQIP versus AQIP (organisational).
ORGANISATIONAL
USUAL QUALITY IMPROVEMENT 
PROGRAM (UQIP)
ADVANCED QUALITY IMPROVEMENT 
PROGRAM (AQIP)
Team changes Interdisciplinary Diabetes Care Team (IDCT) 
operating close to regular care
Active installment of Interdisciplinary Diabetes Care 
Team (IDCT) operating under supervision of a 
diabetologist from a University Hospital
Diabetes Program manager providing logistic support to 
PCPs
---- Introduction of shared care protocol
Active encouragement by IDCT and scientific team 
of PCPs to use shared care protocol
---- Referral arrangements
Active encouragement by IDCT and scientific team to 
adhere to referral arrangements
---- Liaison activities by IDCT towards in-hospital diabetes 
care team in secondary care
---- Involvement of independent pharmacists
Continuous quality improvement Quality Assurance Team Quality Assurance TeamBMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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respectively. Data show that users of the IDCT were
younger (p < 0.0001), represented more men (p = 0.0001)
and were more highly educated compared to non-users of
the IDCT (p = 0.0002). Mean HbA1C was significantly
higher in users of the IDCT (p < 0.0001), as well as mean
DBP (p = 0.0002) and total cholesterol levels (p =
0.0223). The proportion of patients with HbA1C levels
<8% was significantly lower in IDCT users compared to
non-users (p < 0.0001). The use of metformin in case of
obesity was significantly higher in users of the IDCT com-
pared to non-users of the IDCT (p = 0.0008).
Users of the IDCT in the UQIP had worse levels of primary
and secondary endpoints at baseline compared to users of
the IDCT in AQIP. No significant differences in outcome
measures were found at baseline when comparing UQIP
and AQIP[32]. Specific baseline data on comorbidity
revealed no significant differences between users and non
users of the IDCT in both the intervention arms, and irre-
spective of the intervention arm. Comorbidity was pre-
defined as a reported history of heart attack, cerebrovascu-
lar disease, micro-angiopathic complications, history of
angina, hypertension, dyslipidemia, PAD or coronary, cer-
ebral or peripheral vascular intervention in the personal
history and depression.
Use of IDCT in PCPs and patients
A total of 101 PCPs (84%) and 313 patients (12.5%)
made use of the IDCT. More male PCPs (55%) referred
patients to the IDCT compared to their female peers
(45%). PCPs who worked together in the same practice
also made more use of the IDCT compared to PCPs that
did not use the IDCT (63% and 58% respectively).
When comparing the two intervention arms the use of the
IDCT in PCPs and patients was significantly higher in the
AQIP compared to the UQIP (AQIP = 61 PCPs (91%);
UQIP = 40 PCPs (75%); p = 0.02) and (AQIP = 226
patients (14.3%), vs. UQIP = 87 patients (9,4%); p =
0.03), respectively. The number of patients per practice
that were referred to the IDCT ranged from 0-15 in the
AQIP and from 0-16 in the UQIP. An overview on the
IDCT use in both UQIP and AQIP is presented in table 7.
Referral subgroups in AQIP included 138 (8,7%) patients
which consulted the dietician, 107 (6,8%) patients which
consulted the educator, and 79 (5,0%) patients which
Flowchart displaying Enrollment of patients and physicians in the study Figure 1
Flowchart displaying Enrollment of patients and physicians in the study.
Assessed for eligibility
336 PCPs
Randomised (142 PCPs)
90 practices
Excluded: 194 physicians
Reasons: refusal, not meeting the deadline
for inscription
Allocated to AQIP
71 PCPs, 44 practices
Allocated to UQIP
71 PCPs, 46 practices
Initial drop-out:
- 4 PCPs
- Reason: lack of time
Initial drop-out:
- 18 PCPs
- Reason: lack of time, 
retired, maternity leave
Proceed to baseline registration –AQI P-
67 PCPs, 42 practices, 1577 patients
Proceed to baseline registration –UQI P-
53 PCPs, 34 practices, 918 patients
IDCT users: 
- 226 patients 
- 61 PCPs
(924 consultations)
IDCT users:
- 87 patients 
- 40 PCPs
(250 consultations)
Lost to follow-up AQIP: 134 patients, 0 practices
(Patient loss: moved to nursing home, other country, GP)
(Practice loss:lack of time, no electronic doc. of patients)
Lost to follow-up UQIP: 111 patients, 2 practices
(Patient loss: moved to nursing home, other country, GP)
(Practice loss:lack of time, no electronic doc. of patients)
IDCT non-users: 
- 1351 patients 
-6 PCPs
IDCT non-users:
- 831 patients 
- 13 PCPsBMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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Table 5: Baseline information in users and non-users of the IDCT.
IDCT users (n = 313)
Mean (SD)
IDCT non-users (n = 2182)
Mean (SD)
p
Mean age (years) 62.3 (11.5) 68.5 (11.6) <0.0001
Mean diabetes duration (years) 6.5 (6.7) 7.3 (7.1) 0.0674
Female gender (%) 46 52 0.0001
HbA1c (%) 7.8 (1.6) 7.1 (1.2) <0.0001
SBP (mm Hg) 136 (16) 136 (16) 0.8012
DBP (mm Hg) 81.2 (8.6) 79.3 (8.9) 0.0002
T. Chol (mg/dl) 197 (39) 191 (41) 0.0223
LDL-C (mg/dl) 111 (32) 108 (34) 0.1181
HDL-C (mg/dl) 53 (16) 54 (15) 0.4763
BMI 30.4 (5.3) 29.5 (5.3) 0.0087
Duration of insulin therapy 6.2 (7.3) 7.9 (7.6) 0.1820
Education level
Low education level (%) 40 50 0.0002
High education level (%) 20 17 0.0669
Proportion of patients with:
HbA1c < 8% 62 84 <0.0001
HbA1c < 7% 37 57 <0.0001
SBP ≤ 130 (mm Hg) 48 50 0.4892
LDL-C < 100 (mg/dl) 36 42 0.0621
Non smoker (%) 88 85 0.3332
Healthy Diet (%) 63 67 0.1201
Physical Exercise (%) 59 52 0.3597
Aspirin/clopidogrel (%) 35 37 0.0952
ACE/A2A treatment (%) 31 34 0.1945
Statin (%) 37 40 0.3424
Metformin if obesity (%) 71 58 0.0008
Insulin (%) 16 20 0.1063
Complications (microangiopathic) 86 71 0.1351BMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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consulted the internist. The 'travelling educator' was con-
sulted by 40 patients (2,5%) and the health psychologist
by 18 patients (1,1%). Referral subgroups in UQIP for the
dietician, educator and internist included 40 (4,3%), 38
(4,1%) and 29 (3,1%) patients respectively. Patients in
the AQIP represented 79% of all consultations with the
IDCT (AQIP = 924; UQIP = 250). In AQIP the mean con-
sultation rate per patient was 4 and in UQIP 3.
After 18 months of intervention, 27% (n = 598) of the
total patient population did not reach the HbA1c target
and were not referred to the IDCT.
Patients with an HbA1c level between 7% and 8% made
more use of the IDCT compared to patients with HbA1c
levels < 7% (Odds Ratio = 2.0, p = 0.0003). The Odds
Ratio (OR) in patients with HbA1c >8% compared to
patients with an HbA1c < 7% was 3.0 (p < 0.0001). The
OR in patients with an LDL level between 100-115 mg/dl
compared to patients with a level <100 mg/dl was 1.4 (p
= 0.038). The OR in patients with an LDL level ≥ 115 mg/
dl was 1.5 compared to patients with an LDL level < 100
mg/dl (p = 0.0023). The OR in patients with insulin initi-
ation during the project was 5.5 compared to patients
without insulin initiation (p < 0.0001).
Outcomes in users and non-users of the IDCT
After 18 months of intervention the use of the IDCT was
significantly associated with improvements in HbA1c (p =
0.00001) and LDL-cholesterol (p = 0.00039) and an
increase in both the use of statins (p = 0.04308; OR:
1.902) and anti-platelet therapy (p = 0.00544; OR:
2.213). A detailed overview of the evolution in all param-
eters and results for IDCT users and non-users is provided
in table 8. As presented in figure 2. IDCT use was also sig-
nificantly associated with the number of targets that was
reached (p = 0.005).
Outcomes in users of the IDCT in AQIP and UQIP
When comparing the two intervention arms with respect
to the effects of IDCT use on patient outcomes, a signifi-
cant difference was obtained for the use of anti-platelet
therapy only (Table 9).
Discussion
The results of this trial demonstrate that the use of inter-
disciplinary diabetes care teams which are actively guided
and supported by a specialist team from secondary care
are associated with important improvements in outcomes
of care. Another important finding of our study is that the
Table 6: Baseline information in users of the IDCT for UQIP and AQIP.
Users of IDCT (AQIP)
(n = 226)
Mean (SD)
Users of the IDCT (UQIP)
(n = 87)
Mean (SD)
p
HbA1c (%) 7,72 (1.62) 7,98 (1.59) 0.2632
SBP (mm Hg) 135,35 (15.28) 138,85 (19.09) 0.1752
DBP (mm Hg) 80,69 (8.52) 82,62 (8.72) 0.3202
TCHoL (mg/dl) 193,96 (39.51) 204,01 (38.25) 0.0494
LDL CHol (mg/dl) 108,94 (32.56) 115,19 (31.09) 0.2304
HDL CHol (mg/dl) 53,43 (15.83) 53.51 (15.61) 0.9089
BMI 30,49 (5.22) 30,17 (5.52) 0.5399
Targets reached (%) 85 75 0.1324
Smokers (%) 88,35 85,9 0.5571
Healthy diet (%) 62,36 63,89 0.8570
Physical exercise (%) 55,07 69,23 0.0477
Aspirin/clopidogrel (%) 36,56 37,21 0.7233
ACE/A2A treatment (%) 68,72 65,12 0.4532
Statin treatment (%) 40,09 27,91 0.0391BMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
Page 10 of 15
(page number not for citation purposes)
high number of physicians that made use of these teams
demonstrates that the implementation of interdiscipli-
nary shared care in a health care setting with limited tradi-
tion in shared care is feasible. The expected participation
rate of 80% in physicians was easily attained, with physi-
cians in the AQIP to make more use of the IDCT com-
pared to physicians of the UQIP. The latter is possibly
explained since physicians in the AQIP were actively
encouraged by the program manager to make use of the
IDCT whereas physicians in the UQIP were not. These
findings highlight the need for specific implementation
strategies in settings that have limited tradition in shared
care. The higher referral rate in AQIP was however not
associated with better patient outcomes which possibly
indicates that these differences were not large enough to
induce a significant effect. The relative absence of clinical
significant differences between users of the IDCT when
comparing the two intervention arms might also be
related to the limited use of supplementary interventions
as provided to physicians and patients of the AQIP. For
example, very few physicians or their patients consulted
the health psychologist or the travelling educator. These
service offerings were relatively unknown to physicians
and patients prior to the start of the project. Another pos-
sible reason for the aforementioned finding is that
patients in the UQIP that used the IDCT had significantly
worse levels in their outcomes at baseline that allowed for
greater improvements over the 18-month intervention
period.
In contrast to the overall participation rate of physicians,
patients less often made use of the IDCT (12,5%) which
means the expected participation rate of 30% in patients
was not attained. It is not clear to what extent this is
related to either physician referral patterns, patient behav-
iours or both. Physicians generally refer to a diabetes care
team once their threshold for comfort with diabetes man-
agement has been surpassed [33]. In our study higher lev-
els of HbA1c, LDL-cholesterol and insulin initiation
indeed seemed important triggers for referral to the IDCT.
As physicians in our study were recommended to refer to
the IDCT in case the treatment targets were not met, they
Proportions of patients reaching therapeutic targets in users  and non-users of the IDCT Figure 2
Proportions of patients reaching therapeutic targets 
in users and non-users of the IDCT. N = total number of 
included patients in the different subgroups. IDCT+ = group 
of patients who have consulted the IDCT and who presented 
with values of all three primary outcome parameters. IDCT- 
= group of patients who have not consulted the IDCT and 
who presented with values of all three primary outcome 
parameters.
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Table 7: Use of IDCT services by PCPs and patients in UQIP and AQIP.
Type of service offered by IDCT UQIP AQIP
IDCT consultations 87 patients (9.5%) referred by 40 PCPs (75%)
250 consultations (21%)
226 patients (14.3%) referred by 61 PCPs (91%)
924 consultations (79%)
Educator in primary care facility 38 patients (4.1%)
94 consultations
107 patients (6.8%)
256 consultations
Educator at home or in PCP practice NA 40 patients (2.5%)
91 consultations
Dietician 40 patients (4.3%)
63 consultations
138 patients (8.7%)
255 consultations
Internal medical doctor 29 patients (3.1%)
63 consultations
79 patients (5.0%)
164 consultations
Opthalmologist 19 patients (2.1%)
30 consultations
55 patients (3.5%)
85 consultations
Health psychologist NA 18 patients (1.1%)
73 consultations
Printed educational materials for patients NA 126 distributed
Communication forms to PCPs NA 924 reports
Free blood monitoring tools for patients with 
insulin therapy onset
NA 107 distributed
Group information sessions for patient and 
family
NA 7 sessions, 310 participants from 14 physiciansBMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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Table 8: Evolution of variables in all patients (T0: baseline value, T1: value after 18 months of intervention) and IDCT use/non-use.
T0
120 physicians, 67 practices
2495 patients
Mean (SD)
T1
118 physicians, 65 practices
2256 patients
Mean (SD)
Difference between T1-T0 P
HbA1c (%) 7.15 (1.26) 6.76 (0.95) -0.39 <0.0001
IDCT users 7.78 (1.63) 7.00 (1.09) -0.78 <0.0001
IDCT non-users 7.05 (1.16) 6.72 (0.92) -0.33
SBD (mm Hg) 136 (16) 133 (15) -3 <0.0001
IDCT users 136 (16) 133 (15) -3 0.6335
IDCT non-users 136 (16) 133 (15) -3
DBD (mm Hg) 79 (9) 77 (9) -2 <0.0001
IDCT users 81 (9) 79 (9) -2 0.6103
IDCT non-users 79 (9) 77 (9) -2
Tchol (mg/dl) 192 (40) 177 (37) -5 <0.0001
IDCT users 196 (39) 173 (38) -23 0.0002
IDCT non-users 192 (41) 177 (37) -15
HDL-C (mg/dl) 54 (16) 55 (15) +1 0.0006
IDCT users 54 (16) 55 (16) +1 0.8242
IDCT non-users 54 (15) 55 (15) +1
LDL-C (mg/dl) 108 (34) 95 (32) -13 <0,0001
IDCT users 110 (32) 90 (33) -20 0.0012
IDCT non-users 108 (34) 95 (32) -13
BMI (kg/m2) 29.6 (5.3) 29.3 (5.2) -0.3 <0,0001
IDCT users 30.3 (5.4) 30.0 (5.3) -0.3 0.9737
IDCT non-users 29.5 (5.2) 29.2 (5.2) -0.3
Hba1c < 7%, 54% 67% +13% <0.0001
IDCT users 37% 57% +20% 0.07449
IDCT non-users 57% 69% +12%
BMI < 25 kg/m2 18% 20% +2% 0.00108
IDCT users 15% 18% +3% 0.7186BMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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have focused on those patients that showed an important
need for interdisciplinary shared care. Data show however
that a substantial proportion of the patients who did not
reach treatment targets did not make use of the IDCT. This
might in part be explained by clinical inertia in physi-
cians, but it is reasonable to assume that physicians had
difficulty to motivate their patients to consult the IDCT
despite their own convictions on the added value of the
team in the co-management of diabetes. More than 95%
of diabetes care is done by the patient, and health profes-
sionals have very little control over how patients manage
their illness between office visits. Patients manage their
diabetes on a daily basis within the context of the other
goals, priorities, health issues, family demands, and other
personal concerns that make up their lives[34]. Previous
studies have shown that patients with diabetes often show
poor compliance with diet, exercise, medication regimen
and even appointment compliance[35]. These behaviours
are in their turn affected by numerous variables, such as
the nature of the patient-physician relationship, complex-
ity of regimen, disruption of lifestyle, emotional support,
financial resources, education in self-management skills,
cues to action, perceived barriers, locus of control and
motivation[36]. In our study patients who were not at tar-
get might have been unwilling to consult the IDCT,
despite recommendations of their PCPs. These findings
highlight the need for ongoing patient empowerment
strategies in the context of the physician-patient relation-
ship as well as clear referral indications in order to prevent
over and under use of interdisciplinary shared care serv-
ices in both physicians and patients. The broad referral
indication that was applied in our project was probably
not specific enough to guide PCPs in their decision to refer
patients to the IDCT. The American Diabetes Association
IDCT non-users 19% 21% +2%
Non smokers 86% 89% +3% 0.023
IDCT users 88% 89% +1% 0.2675
IDCT non-users 85% 89% +4%
Healthy nutrition 67% 75% +8% <0.0001
IDCT users 63% 77% + 4% 0.9885
IDCT non-users 67% 75% +8%
Physical exercise 53% 60% +7% 0.00035
IDCT users 59% 71% +12% 0.3349
IDCT non-users 52% 59% +7%
Aspirin/clopidogrel 40% 57% +17% <0.0001
IDCT users 37% 67% +30% 0.005644
IDCT non-users 40% 56% +16%
ACE/A2A 73% 78% +5% <0.0001
IDCT users 68% 76% +8% 0.3954
IDCT non-users 74% 78% +4%
Statins 39% 53% +14% <0.0001
IDCT users 37% 57% +20% 0.04431
IDCT non-users 40% 53% +13%
Table 8: Evolution of variables in all patients (T0: baseline value, T1: value after 18 months of intervention) and IDCT use/non-use. BMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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(ADA) standards currently do not indicate a minimum
frequency for the provision of diabetes education, includ-
ing dietary advice[4]. Other and clearer referral criteria for
specialist services defined by the ADA are e.g. recurrent
hypoglycaemia, poor glycaemic control and persistent
hypertension and/or hyperlipidaemia despite intensive
management and the need for psychosocial/counselling
support to overcome barriers to self-care.
As an explanation to the positive results that are associ-
ated with the use of the IDCT we assume that particular
team characteristics such as quality task orientation and
shared leadership with clearly defined and valued group
goals that the teams were trained at prior to the interven-
tion might possibly have contributed to the success of the
team. There is an extensive basis of research demonstrat-
ing the aforementioned team characteristics are associated
with improved outcomes of care [37-39].
Limitations to our study design are twofold. The UK Med-
ical Research Council (MRC) Framework that we used for
the development of our complex intervention demon-
strated the difficulty of balancing optimum study design
with designing interventions that were practical enough to
be applied in family practice. The MRC Framework pro-
vides a methodological rather than an explanatory
approach to evaluating complex interventions. This
means that in order to fully understand and predict prob-
lems of workability and integration of complex interven-
tions the additional use of psychological and sociological
models is important in the design and evaluation of com-
plex interventions. The Normalization Process Model [40]
is a recent sociological model that asks what people do to
make a complex intervention workable, and to integrate it
in practice. The model proposes that complex interven-
tions are implemented in processes in which the collective
action and interaction of patients, professionals and oth-
ers are governed by four factors. These factors are interac-
tional and skill-set workability and relational and
contextual integration. Since we did not make use of such
additional social and psychological models in the design
of our program, we recognize this is a limitation to our
study protocol. We also have not integrated qualitative
methods within the context of a pilot trial that could have
helped to interpret the quantitative results of the pilot tri-
als by clarifying process and outcome results. What we
consider a particular strength of the study is it provides
answers to hypotheses on innovative types of change
interventions (such as interdisciplinary teams operating
on the primary-specialty care interface). These hypotheses
were tested using a large group of physicians and patients
during an 18-month period. Most quality improvement
programs reduce the intervention period to six months
and are limited to smaller groups. A six-month period is
short considering the Hawthorne effect that probably has
not been washed out. Another strength of our study is that
the primary and secondary care interface is strongly val-
ued since we recognize a well-operationalized interface as
an important attribute to high quality diabetes care [41].
More specific, the clinical leadership and coaching pro-
vided by a diabetologist to both the primary care physi-
cians and the interdisciplinary diabetes care team is of
particular importance in fragmented health care systems
including the one from Belgium. Another strength of the
study is the explicit project focus on multiple cardiovascu-
lar risk factors. A systematic review published in 2001
observed that most interventions did not pay enough
attention to patient outcomes and if so, only changes in
glycemic control were evaluated [42]. A last strength of the
study is the use of all six dimensions of the Chronic Care
Model (CCM), which is to our knowledge the fourth study
in the field of diabetes care to do so [43-45]. The use of all
six dimensions of the CCM allows for an evaluation how
some of the CCM components are associated with
improved outcomes and thus it provides evidence to sup-
port the validity of this model.
Table 9: Effect of IDCT use in AQIP compared to UQIP*.
Estimate StdErr P-value
HbA1c (%) 0.0848 0.1476 0.5656
SBP (mm Hg) 2.3901 2.2566 0.2896
DBP (mm Hg) 0.4532 1.3308 0.7335
T. Chol (mg/dl) 1.8074 5.379 0.7369
LDL-CL (mg/dl) 0.1833 4.686 0.9688
HDL-C (mg/dl) -1.4947 1.4404 0.2995
BMI 0.0092 0.2799 0.9737
Targets (%) -0.3404 0.4078 0.4039
Non smoker (%) 1.0710 1.3691 0.4341
Health diet (%) 0.4817 0.6984 0.4904
Physical exercise (%) 1.0129 0.6550 0.1221
Aspirin/clopidogrel (%) 1.3368 0.5702 0.0119
ACE/A2A treatment (%) 1.4285 0.7558 0.0584
Statin treatment (%) 0.2726 0.6341 0.1766
* Reported estimates represent the difference of the effect of IDCT 
use on each outcome in the AQIP group and the effect of IDCT use in 
the UQIP group.BMC Health Services Research 2009, 9:179 http://www.biomedcentral.com/1472-6963/9/179
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Future research that will complement this present study
will include 1. a qualitative analysis on perceived barriers
to high quality diabetes through PCPs eyes, 2. a quantita-
tive study on how patients' experiences with perceived
quality of patient-centered care and self-management sup-
port are associated with documented diabetes outcome of
care indicators and 3. a health economic assessment of the
cost-effectiveness of the trial.
Overall, we assume that the increasing prevalence of dia-
betes, combined with its complexity, rapidly evolving
medical therapies and the requirement for patient self-
management will lead to a growing demand for multifac-
eted and interdisciplinary shared care services that target
improvements in diabetes care[46].
Conclusion
Interdisciplinary care teams that are part of a multifaceted
quality improvement program are associated with
improved outcomes of care. More research is however
required on what type of team and program characteristics
contribute to improvements in diabetes care. There is a
particular need for clear referral indications in order to
prevent over and underuse of interdisciplinary care serv-
ices in persons with type 2 DM.
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